Innovent Biologics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-94.63	-1,028	-2,179	-2,729
Depreciation & Amortization	332.16	310.22	276.79	202.17
Other Amortization	87.61	74.89	42.64	2.58
Loss (Gain) From Sale of Assets	22.99	0.95	-0.06	0.71
Asset Writedown & Restructuring Costs	632.57	115.36	-	-
Loss (Gain) From Sale of Investments	-179.03	-30.81	-5.1	-125.02
Loss (Gain) on Equity Investments	41.01	-	-	-
Stock-Based Compensation	556.52	574.2	469.49	501.57
Other Operating Activities	-515.93	-272.47	-833.19	213.88
Change in Accounts Receivable	-178.52	-430.62	393.14	-493.03
Change in Inventory	180.63	358.95	-105.39	-643.28
Change in Accounts Payable	-14.87	46.93	130.57	74.43
Change in Unearned Revenue	-31.19	-138.63	205.04	105.43
Change in Other Net Operating Assets	447.71	566.77	-313.45	864.46
Operating Cash Flow	1,287	147.81	-1,919	-2,025
Operating Cash Flow Growth	770.73%	-	-	-
Capital Expenditures	-965.67	-1,119	-896.9	-1,066
Sale of Property, Plant & Equipment	0.27	0.05	0.19	0.1
Sale (Purchase) of Intangibles	-676.42	-262.35	-468.6	-781.88
Sale (Purchase) of Real Estate	-	16.23	-	-
Investment in Securities	-981.19	-204.43	-384.74	-254.58
Other Investing Activities	1,458	571.22	314.87	-596.15
Investing Cash Flow	-1,165	-998.66	-1,435	-2,698
Long-Term Debt Issued	515.57	1,336	1,080	1,463
Long-Term Debt Repaid	-1,246	-948.85	-392.74	-278.72
Net Debt Issued (Repaid)	-730.44	386.7	687.43	1,184
Issuance of Common Stock	84.31	2,255	2,131	3,951
Other Financing Activities	39.5	-54.56	73.59	-131.52
Financing Cash Flow	-606.63	2,587	2,892	5,003
Foreign Exchange Rate Adjustments	12.68	-6.88	118.66	-197.14
Net Cash Flow	-472.34	1,730	-343.24	83.23
Free Cash Flow	321.36	-971.58	-2,816	-3,090
Free Cash Flow Margin	3.41%	-15.65%	-61.80%	-72.38%
Free Cash Flow Per Share	0.20	-0.62	-1.89	-2.12
Cash Interest Paid	122.43	127.61	104.88	78.83
Cash Income Tax Paid	0.16	-114.42	66.1	26.44
Levered Free Cash Flow	-113.22	-907.54	-2,475	-2,612
Unlevered Free Cash Flow	-70.94	-845.9	-2,411	-2,573
Change in Working Capital	403.76	403.39	309.91	-91.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.